Anti-Calpain Small Subunit 1 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody targeting Calpain small subunit 1 (CAPNS1), the regulatory subunit of calcium-dependent calpain proteases, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential
UniProt
P04632
Size
100ug
Cat. #
RP1CalpainS1

In stock

SKU
RP-CalpainS1

Options

As low as: $130.00

Target Overview

Calpain small subunit 1 (CAPNS1, UniProt P04632), also known as the calpain regulatory subunit, is the 268-amino acid regulatory component of the calcium-regulated non-lysosomal thiol-protease family. This cytoplasmic protein associates with the catalytic large subunits of both μ-calpain (CAPN1) and m-calpain (CAPN2) to form heterodimeric cysteine proteases that catalyze limited proteolysis of numerous substrates involved in cytoskeletal remodeling, cell migration, and signal transduction. The small subunit contains a glycine-rich N-terminal domain (domain V) and five EF-hand calcium-binding motifs (domain VI), which are essential for calcium-dependent activation and membrane translocation of the holoenzyme. CAPNS1 is essential for embryonic development and is ubiquitously expressed across tissues. Researchers study this regulatory subunit to understand calpain activation mechanisms, calcium-dependent proteolysis in physiological contexts, and pathological conditions including ischemia-reperfusion injury, neurodegeneration, and endoplasmic reticulum stress responses.

Background

The calpain system comprises calcium-dependent cysteine proteases that perform selective, limited proteolysis distinct from degradative pathways. CAPNS1 is shared by multiple calpain isoforms and is required for stabilization of the catalytic subunit, calcium binding, and enzymatic activity. Upon calcium influx, conformational changes in both subunits lead to membrane association and substrate cleavage. Calpain substrates span diverse functional categories including cytoskeletal proteins (spectrin, talin), kinases, phosphatases, and transcription factors. Dysregulated calpain activity contributes to pathology in cardiac ischemia-reperfusion injury, where calpain-mediated cleavage of mitochondrial respiratory chain components exacerbates cellular damage (Li et al., 2022; Chen et al., 2024). Recent work has clarified the role of calpains in endoplasmic reticulum stress. Mohsin et al. (2020) demonstrated that ER stress-induced calcium overload triggers calpain activation, leading to mitochondrial complex I deficiency through proteolytic degradation of NDUFS7 and NDUFS3 subunits. This calcium-calpain-mitochondria axis represents a critical node in cellular stress responses. Calpain activity is also implicated in apoptosis regulation, with CAPNS1 detected in proteomic analyses of TRAIL resistance pathways in myeloma and pancreatic islet physiology. Selective calpain inhibitors and genetic models targeting CAPNS1 continue to reveal both redundant and unique functions of individual calpain isoforms, underscoring the importance of characterizing the regulatory subunit in addition to catalytic components.

References

  1. Chen Q et al (2024) Acute endoplasmic reticulum stress-induced mitochondria respiratory chain damage: The role of activated calpains. FASEB J. PubMed · DOI
  2. Li L et al (2022) Calpain-mediated protein targets in cardiac mitochondria following ischemia-reperfusion. Sci Rep. PubMed · DOI
  3. Mohsin AA et al (2020) Endoplasmic reticulum stress-induced complex I defect: Central role of calcium overload. Arch Biochem Biophys. PubMed · DOI
  4. Nakashima Y et al (2017) A proteome analysis of pig pancreatic islets and exocrine tissue by liquid chromatography with tandem mass spectrometry. Islets. PubMed · DOI
  5. Jian Y et al (2016) Target and resistance-related proteins of recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand on myeloma cell lines. Biomed Rep. PubMed · DOI

Additional Specifications

Gene Symbol CPNS1
UniProt ID P04632
Host Species Rabbit
Species Reactivity Validated- Human
Potential
Pack Size 100ug
Immunogen (Aminoterminal end Domain-V, Small subunit)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-51.
Immunogen (Carboxyterminal end Domain-V, Small subunit)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 218-268.
Immunogen (Aminoterminal end Domain-VI, Small subunit)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-51.
Immunogen (Carboxyterminal end Domain-VI, Small subunit)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 218-268.
Alternate Names CAPNS1, CPNS1, Calpain small subunit 1, CSS1, Calcium-activated neutral proteinase small subunit, CANP small subunit, Calcium-dependent protease small subunit, CDPS, Calcium-dependent protease small subunit 1, Calpain regulatory subunit

Frequently Asked Questions

What molecular weight band should I expect for CAPNS1 on Western blot?

CAPNS1 migrates at approximately 28 kDa on SDS-PAGE, corresponding to its 268-amino acid sequence. You may observe the band slightly above the predicted mass depending on gel percentage and running conditions. The small subunit runs well-separated from the catalytic large subunits CAPN1 (80 kDa) and CAPN2 (80 kDa), making identification straightforward in whole cell lysates. If you are working with tissue samples where calpain is abundant, you should see a single clean band at 28 kDa with minimal background at the recommended 1:1000 dilution.

Does this antibody detect both mu-calpain and m-calpain complexes?

Yes. CAPNS1 is the common regulatory subunit shared by both μ-calpain (CAPN1/CAPNS1 heterodimer) and m-calpain (CAPN2/CAPNS1 heterodimer). This antibody detects CAPNS1 regardless of which catalytic subunit it associates with, so it reports total small subunit expression rather than distinguishing between the two calpain isoforms. If you need to differentiate μ- versus m-calpain activity or localization, you will need separate antibodies against CAPN1 or CAPN2. Co-immunoprecipitation experiments can confirm complex formation if that is your experimental goal.

What dilution should I start with for Western blot of CAPNS1?

Start at 1:1000 in your blocking buffer for overnight incubation at 4°C or 1-2 hours at room temperature. CAPNS1 is typically expressed at moderate to high levels in most cell types, so this dilution provides a good signal-to-noise ratio without excessive background. If your signal is weak in low-abundance samples such as certain differentiated primary cells, you can increase concentration to 1:500. Conversely, in calpain-rich tissues like skeletal muscle or brain lysates, 1:2000 may suffice. Always titrate against your specific sample type and detection system.

Is this antibody validated in mouse or rat samples?

This antibody has been validated in human samples. Mouse and rat CAPNS1 share approximately 95-97% sequence identity with human CAPNS1, so cross-reactivity is likely but not experimentally confirmed by us. If you are working with rodent samples, we recommend treating this as predicted reactivity and including a positive control such as HeLa or HEK293 lysate alongside your experimental samples on the same blot. Many researchers have successfully used human CAPNS1 antibodies in mouse and rat, but you should verify band specificity at 28 kDa in your system.

What controls should I include when blotting for CAPNS1?

Include a positive control lysate from a human cell line such as HeLa, Jurkat, or HEK293, where CAPNS1 is constitutively expressed. For a negative control, consider lysate from cells treated with CAPNS1 siRNA or CRISPR knockout if available, though wildtype versus treated comparisons are usually sufficient. Loading controls such as beta-actin or GAPDH are essential since CAPNS1 levels can vary with cell density and calcium signaling status. If investigating calcium-dependent translocation, fractionate cytosolic and membrane fractions and blot separately; CAPNS1 should shift to membrane fractions upon calcium stimulation.

Can I use this antibody for immunofluorescence of CAPNS1?

Triple Point Biologics antibodies are routinely validated for immunofluorescence applications in addition to Western blot. For CAPNS1, start with a 1:100 to 1:200 dilution for IF. You should observe diffuse cytoplasmic staining under basal conditions, with potential enrichment at the plasma membrane or focal adhesions upon calcium ionophore treatment such as A23187 or ionomycin. Methanol fixation at -20°C often gives cleaner staining for cytoplasmic proteases than paraformaldehyde. Include a no-primary-antibody control to assess non-specific secondary binding, particularly in cells with high autofluorescence.

How should I store this Calpain-S1 antibody and what is the shelf life?

Store at -20°C in the supplied glycerol-based buffer. Avoid repeated freeze-thaw cycles by making single-use aliquots if you use the antibody infrequently. Under these conditions, the antibody remains stable for at least 12 months from date of receipt. If you notice increased background or diminished signal over time, this typically indicates degradation or contamination. Do not store diluted antibody in blocking buffer for more than one week at 4°C. For long-term storage beyond one year, -80°C is preferable, though most labs find -20°C adequate for routine use.

Does calcium in my lysis buffer affect CAPNS1 detection?

CAPNS1 itself remains detectable regardless of calcium concentration, but be aware that active calpain will proteolyze many substrates if calcium is present during lysis. Use EDTA or EGTA-containing lysis buffers (1-5 mM) to chelate calcium and prevent artifactual proteolysis during sample preparation. Some protocols also include calpain inhibitors such as calpeptin or MDL28170 as an extra precaution. If you are specifically studying calcium-dependent calpain activation or autolysis, include calcium and collect samples rapidly on ice, then compare CAPNS1 levels and cleavage products between calcium-treated and chelator-treated lysates.

Western blot validation for RP-CalpainS1 — 4 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Calpain-S1: Aminoterminal end Domain-V, Small subunit — WB validation
WB · Panel 1 Calpain-S1: Aminoterminal end Domain-V, Small subunit
Calpain-S1: Carboxyterminal end Domain-V, Small subunit — WB validation
WB · Panel 2 Calpain-S1: Carboxyterminal end Domain-V, Small subunit
Calpain-S1: Aminoterminal end Domain-VI, Small subunit — WB validation
WB · Panel 3 Calpain-S1: Aminoterminal end Domain-VI, Small subunit
Calpain-S1: Carboxyterminal end Domain-VI, Small subunit — WB validation
WB · Panel 4 Calpain-S1: Carboxyterminal end Domain-VI, Small subunit

Custom validation studies available on request — contact us.

Also known as:

  • CAPNS1
  • CPNS1
  • Calpain small subunit 1
  • CSS1
  • Calcium-activated neutral proteinase small subunit
  • CANP small subunit
  • Calcium-dependent protease small subunit
  • CDPS
  • Calcium-dependent protease small subunit 1
  • Calpain regulatory subunit
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →